Clinical Lymphoma Myeloma & Leukemia · 2015 · 69 citations · 22 references
PharmacyPharmacologyPharmacotherapyImmunotherapyMonoclonal AntibodiesRenal PharmacokineticsCancer ImmunotherapyImmunotherapy SafetyMultiple MyelomaPharmacokinetics In Renal ImpairmentPharmacokinetics Of ImmunotherapiesPharmacokinetics Of Monoclonal AntibodiesEnd-stage Renal Disease PharmacokineticsHumanized Monoclonal AntibodiesLenalidomide TherapyMonoclonal Antibody TherapeuticsMultiple Myeloma TherapyMultiple Myeloma TreatmentRenal Function EvaluationRenal Function Loss
22
International uniform response criteria for multiple myeloma
Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al. · Leukemia · 2006 · 2.6K citations
Medicine, Hematology, Oncology +12
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo et al. · New England Journal of Medicine · 2015 · 1.3K citations · Full text
Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America
Donna M. Weber, Christine Chen, Rubén Niesvizky et al. · New England Journal of Medicine · 2007 · 1.2K citations · Full text